CKPT
Price:
$4.26
Market Cap:
$367.72M
Checkpoint Therapeutics, Inc. is a clinical-stage company specializing in immunotherapy and targeted oncology. Its mission involves discovering, advancing, and bringing to market innovative therapeutic solutions for individuals battling solid tumor cancers. The company's pipeline features several key candidates, including Cosibelimab, a leading fully-human IgG1 monoclonal antibody. This therapy is designed to directly bind to programmed death ligand-1 (PD-L1), thereby inhibiting its interaction with programmed death receptor-1 and B7.1 receptors. Another significant antibody in development is CK-302, a human agonistic antibody intended to bind and activate signaling within GITR-expressing ce...[Read more]
Industry
Biotechnology
IPO Date
2016-12-19
Stock Exchange
NASDAQ
Ticker
CKPT
According to Checkpoint Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -2185.94%. This represents a change of -3226.12% compared to the average of 69.93% of the last 4 quarters.
The mean historical ROE of Checkpoint Therapeutics, Inc. over the last ten years is 21.93%. The current -2185.94% ROE has changed -10067.78% with respect to the historical average. Over the past ten years (40 quarters), CKPT's ROE was at its highest in in the September 2022 quarter at 787.12%. The ROE was at its lowest in in the June 2022 quarter at -188.93%.
Average
21.93%
Median
-67.38%
Minimum
-308.04%
Maximum
445.47%
Discovering the peaks and valleys of Checkpoint Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 191.75%
Maximum Annual ROE = 445.47%
Minimum Annual Increase = -268.88%
Minimum Annual ROE = -308.04%
| Year | ROE | Change |
|---|---|---|
| 2024 | 445.47% | 12.10% |
| 2023 | 397.39% | 23.63% |
| 2022 | 321.43% | -268.88% |
| 2021 | -190.33% | 191.75% |
| 2020 | -65.24% | -50.25% |
| 2019 | -131.13% | -57.43% |
| 2018 | -308.04% | 104.31% |
| 2017 | -150.77% | 116.85% |
| 2016 | -69.53% | 132.21% |
The current ROE of Checkpoint Therapeutics, Inc. (CKPT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
388.09%
5-year avg
181.74%
10-year avg
21.93%
Checkpoint Therapeutics, Inc.’s ROE is greater than Vigil Neuroscience, Inc. (-122.87%), less than Orchard Therapeutics plc (-5.12%), less than Revance Therapeutics, Inc. (466.15%), greater than Climb Bio, Inc. (-31.46%), greater than G1 Therapeutics, Inc. (-92.13%), less than scPharmaceuticals Inc. (1.29%), less than Y-mAbs Therapeutics, Inc. (-16.98%), greater than iTeos Therapeutics, Inc. (-28.60%), less than SomaLogic, Inc. (-18.59%), greater than Inozyme Pharma, Inc. (-122.99%),
| Company | ROE | Market cap |
|---|---|---|
| -122.87% | $375.71M | |
| -5.12% | $380.11M | |
| 466.15% | $381.02M | |
| -31.46% | $780.71M | |
| -92.13% | $377.75M | |
| 1.29% | $302.20M | |
| -16.98% | $391.22M | |
| -28.60% | $448.68M | |
| -18.59% | $396.23M | |
| -122.99% | $258.25M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Checkpoint Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Checkpoint Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Checkpoint Therapeutics, Inc.'s ROE?
How is the ROE calculated for Checkpoint Therapeutics, Inc. (CKPT)?
What is the highest ROE for Checkpoint Therapeutics, Inc. (CKPT)?
What is the 3-year average ROE for Checkpoint Therapeutics, Inc. (CKPT)?
What is the 5-year average ROE for Checkpoint Therapeutics, Inc. (CKPT)?
How does the current ROE for Checkpoint Therapeutics, Inc. (CKPT) compare to its historical average?